Arcadia Biosciences, Inc. (RKDA)

Arcadia Biosciences' stock price has been impacted by several events in the past six months. These events include the exercise of preferred investment options, the termination notice for its proposed business combination with Roosevelt Resources, stockholder support for directors and governance moves, and the reporting of Q3 profits driven by Zola coconut water growth. The company released its Q3 and Q2 2025 financial results, highlighting revenue increases and gross profit margins. The stock price experienced a significant decline of 60.49% from February 5, 2025, to February 4, 2026.

The provided information does not explicitly detail any specific demand seasonality for Arcadia Biosciences, Inc.'s products and services. The company's focus on plant-based food ingredients and health and wellness products suggests it may be influenced by general consumer trends in these markets, but no distinct seasonal patterns were identified in the search results.

Arcadia Biosciences is an agricultural biotechnology company that develops crops and food ingredients focused on health and sustainability. It operates through two segments: Crop Traits, which licenses seed traits, and Food Ingredients, which produces plant-based ingredients like GoodWheat™ and Zola® coconut water. Zola coconut water is the company's primary revenue source. The company exited body care operations.

Arcadia Biosciences conducts field trials and pilot programs across North America, Australia, and Latin America. The company's operations span geographical segments including the United States, Argentina, India, and Canada, serving a worldwide market.

Arcadia Biosciences has received a consensus "Sell" rating from analysts. The company's reputation has been influenced by news of investigations by law firms concerning the fairness of the proposed acquisition/merger with Roosevelt Resources. CEO and CFO purchasing company stock in February 2025 could be seen as a positive signal. The consistent growth of its Zola coconut water brand and the expansion of its GoodWheat product line contribute positively to its market presence.

Arcadia Biosciences has 16 institutional owners and shareholders who collectively hold 64,928 shares. Major institutional shareholders include Vanguard Group Inc., Geode Capital Management, Llc, Mariner, LLC, and State Street Corp. Insider ownership is reported as 0.82% and 8.20%, while institutional ownership is stated as 4.33% and 17.73%. The company is also partly owned by Moral Compass Corporation.